Conditional knockout of fibronectin abrogates mouse mammary gland lobuloalveolar differentiation

Developmental Biology

Volumn 346, Issue 1, 2010, Pages 11-24

  Liu, Keyi ^a   Cheng, Le ^a   Flesken Nikitin, Andrea ^a   Huang, Lynn ^a   Nikitin, Alexander Y ^a   Pauli, Bendicht U ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Conditional knockout; Fibronectin; Lobuloalveolar differentiation; Mammary epithelial cell proliferation

Indexed keywords

BETA1 INTEGRIN; CRE RECOMBINASE; FIBRONECTIN; FOCAL ADHESION KINASE; BROXURIDINE; CD31 ANTIGEN; CYTOKERATIN 8; INTEGRASE; KRT8 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPHOSPHORYLATION; BREAST APLASIA; BREAST DEVELOPMENT; BREAST EPITHELIUM; BREAST HYPOPLASIA; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; EPITHELIUM CELL; FEMALE; GENE DELETION; LOBULOALVEOLAR DIFFERENTIATION; LUNG ALVEOLUS CELL; MALE; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANGIOGENESIS; ANIMAL; CYTOLOGY; GENETIC RECOMBINATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HYPERPLASIA; METABOLISM; MORPHOGENESIS; MOUSE MAMMARY TUMOR ONCOVIRUS; PATHOLOGY; PHYSIOLOGY; UDDER; VASCULARIZATION;

MUS;

ANIMALS; ANTIGENS, CD29; ANTIGENS, CD31; BROMODEOXYURIDINE; CELL DIFFERENTIATION; FEMALE; FIBRONECTINS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HYPERPLASIA; INTEGRASES; KERATIN-8; MAMMARY GLANDS, ANIMAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MORPHOGENESIS; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; RECOMBINATION, GENETIC;

EID: 77956415937     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2010.07.001     Document Type: Article

References (61)

1. Abbi S., Guan J.L. Focal adhesion kinase: protein interactions and cellular functions. Histol. Histopathol. 2002, 17:1163-1171.
2. Abdel-Ghany M., Cheng H.C., Elble R.C., Pauli B.U. Focal adhesion kinase activated by beta(4) integrin ligation to mCLCA1 mediates early metastatic growth. J. Biol. Chem. 2002, 277:34391-34400.
3. Adams J.C., Watt F.M. Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature 1989, 340:307-309.
4. Bonnerot C., Nicolas J.F. Application of LacZ gene fusions to postimplantation development. Methods Enzymol. 1993, 225:451-469.
5. Brill B., Boecher N., Groner B., Shemanko C.S. A sparing procedure to clear the mouse mammary fat pad of epithelial components for transplantation analysis. Lab Anim. 2008, 42:104-110.
6. Cheng H.C., Abdel-Ghany M., Pauli B.U. A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis. J. Biol. Chem. 2003, 278:24600-24607.
7. Danen E.H., Yamada K.M. Fibronectin, integrin, and growth control. J. Cell. Physiol. 2001, 189:1-13.
8. DeOme K.B., Faulkin L.J., Bern H.A., Blair P.B. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res. 1959, 19:515-520.
9. Djonov V., Baum O., Burri P.H. Vascular remodeling by intussusceptive angiogenesis. Cell Tissue Res. 2003, 314:107-117.
10. Faraldo M.M., Deugnier M.A., Lukashev M., Thiery J.P., Glukhova M.A. Perturbation of beta1-integrin function alters the development of murine mammary gland. EMBO J. 1998, 17:2139-2147.
11. Fata J.E., Werb Z., Bissell M.J. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res. 2004, 6:1-11.
12. Fendrick J.L., Raafat A.M., Haslam S.Z. Mammary gland growth and development from the postnatal period to postmenopause: ovarian steroid receptor ontogeny and regulation in the mouse. J. Mammary Gland Biol. Neoplasia 1998, 3:7-22.
13. ffrench-Constant C. Alternative splicing of fibronectin-many different proteins but few different functions. Exp. Cell Res. 1995, 221:261-271.
14. Geiger B., Bershadsky A., Pankov R., Yamada K.M. Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat. Rev. Mol. Cell Biol. 2001, 2:793-805.
15. George E.L., Georges-Labouesse E.N., Patel-King R.S., Rayburn H., Hynes R.O. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 1993, 119:1079-1091.
16. Haslam S.Z., Woodward T.L. Host microenvironment in breast cancer development: epithelial-cell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland. Breast Cancer Res. 2003, 5:208-215.
17. Hennighausen L., Robinson G.W. Signaling pathways in mammary gland development. Dev. Cell 2001, 1:467-475.
18. Hennighausen L., Robinson G.W. Information networks in the mammary gland. Nat. Rev. Mol. Cell Biol. 2005, 6:715-725.
19. Hsia D.A., Mitra S.K., Hauck C.R., Streblow D.N., Nelson J.A., Ilic D., Huang S., Li E., Nemerow G.R., Leng J., Spencer K.S., Cheresh D.A., Schlaepfer D.D. Differential regulation of cell motility and invasion by FAK. J. Cell Biol. 2003, 160:753-767.
20. Huang L., Cheng H.C., Isom R., Chen C.S., Levine R.A., Pauli B.U. Protein kinase C epsilon mediates fibronectin assembly on the surface of blood-borne rat breast cancer cells to promote pulmonary metastasis. J. Biol. Chem. 2008, 283:7616-7627.
21. Hynes R.O. Fibronectin 1990, Springer-Verlag, New York.
22. Jiang B., Liou G.I., Behzadian M.A., Caldwell R.B. Astrocytes modulate retinal vasculogenesis: effects on fibronectin expression. J. Cell Sci. 1994, 107:2499-2508.
23. Jiang X., Rowitch D.H., Soriano P., McMahon A.P., Sucov H.M. Fate of the mammalian cardiac neural crest. Development 2000, 27:1607-1616.
24. Johansson S., Svineng G., Wennerberg K., Armulik A., Lohikangas L. Fibronectin-integrin interactions. Front. Biosci. 1997, 2:d126-d146.
25. Khan Z.A., Cukiernik M., Gonder J.R., Chakrabarti S. Oncofetal fibronectin in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2004, 45:287-295.
26. Khan Z.A., Chan B.M., Uniyal S., Barbin Y.P., Farhangkhoee H., Chen S., Chakrabarti S. EDB fibronectin and angiogenesis-a novel mechanistic pathway. Angiogenesis 2005, 8:183-196.
27. Kumar C.C. Signaling by integrin receptors. Oncogene 1998, 17:1365-1373.
28. Larsen M., Wei C., Yamada K.M. Cell and fibronectin dynamics during branching morphogenesis. J. Cell Sci. 2006, 119:3376-3384.
29. Lefcort F., Venstrom K., McDonald J.A., Reichardt L.F. Regulation of expression of fibronectin and its receptor, alpha 5 beta 1, during development and regeneration of peripheral nerve. Development 1992, 116:767-782.
30. Leiss M., Beckmann K., Girós A., Costell M., Fässler R. The role of integrin binding sites in fibronectin matrix assembly in vivo. Curr. Opin. Cell Biol. 2008, 20:502-507.
31. Li N., Zhang Y., Naylor M.J., Schatzmann F., Maurer F., Wintermantel T., Schuetz G., Mueller U., Streuli C.H., Hynes N.E. beta1 Integrins regulate mammary gland proliferation and maintain the integrity of mammary alveoli. EMBO J. 2005, 24:1942-1953.
32. Mitra S.K., Schlaepfer D.D. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr. Opin. Cell Biol. 2006, 18:516-523.
33. Miyamoto S., Katz B.Z., Lafrenie R.M., Yamada K.M. Fibronectin and integrins in cell adhesion, signaling, and morphogenesis. Ann. N. Y. Acad. Sci. 1998, 857:119-129.
34. Nagy T., Wei H., Shen T.L., Peng X., Liang C.C., Gan B., Guan J.L. Mammary epithelial-specific deletion of the focal adhesion kinase gene leads to severe lobuloalveolar hypoplasia and secretory immaturity of the murine mammary gland. J. Biol. Chem. 2007, 282:31766-31776.
35. Naylor M.J., Li N., Cheung J., Lowe E.T., Lambert E., Marlow R., Wang P., Schatzmann F., Wintermantel T., Schuetz G., Clarke A.R., Mueller U., Hynes N.E., Streuli C.H. Ablation of beta1 integrin in mammary epithelium reveals a key role for integrin in glandular morphogenesis and differentiation. J. Cell Biol. 2005, 171:717-728.
36. Pankov R., Yamada K.M. Fibronectin at a glance. J. Cell Sci. 2002, 115:3861-3963.
37. Pauli B.U., Cohen S.M., Weinstein R.S. Cellular changes in rat urinary bladder carcinomas induced by FANFT: A quantitative electron microscopic analysis. J. Urol. 1983, 129:646-652.
38. Pepper M.S., Baetens D., Mandriota S.J., Di Sanza C., Oikemus S., Lane T.F., Soriano J.V., Montesano R., Iruela-Arispe M.L. Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution. Dev. Dyn. 2000, 218:507-524.
39. Qiu Y., Bevan H., Weeraperuma S., Wratting D., Murphy D., Neal C.R., Bates D.O., Harper S.J. Mammary alveolar development during lactation is inhibited by endogenous antiangiogenic growth factor isoform, VEGF165b. FASEB J. 2008, 22:1104-1112.
40. Rongish B.J., Hinchman G., Doty M.K., Baldwin H.S., Tomanek R.J. Relationship of the extracellular matrix to coronary neovascularization during development. J. Mol. Cell. Cardiol. 1996, 28:2203-2215.
41. Rossiter H., Barresi C., Ghannadan M., Gruber F., Mildner M., Födinger D., Tschachler E. Inactivation of VEGF in mammary gland epithelium severely compromises mammary gland development and function. FASEB J. 2007, 21:3994-4004.
42. Sakai T., Johnson K.J., Murozono M., Sakai K., Magnuson M.A., Wieloch T., Cronberg T., Isshiki A., Erickson H.P., Fässler R. Plasma fibronectin supports neural survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nat. Med. 2001, 7:324-330.
43. Sakai T., Larsen M., Yamada K.M. Fibronectin requirement in branching morphogenesis. Nature 2003, 423:876-881.
44. Schlaepfer D.D., Hunter T. Integrin signaling and tyrosine phosphorylation: just the FAKs?. Trends Cell Biol. 1998, 8:151-157.
45. Shen Q., Zhang Y., Uray I.P., Hill J.L., Kim H.T., Lu C., Young M.R., Gunther E.J., Hilsenbeck S.G., Chodosh L.A., Colburn N.H., Brown P.H. The AP-1 transcription factor regulates postnatal mammary gland development. Dev. Biol. 2006, 295:589-603.
46. Shillingford J.M., Hennighausen L. Experimental mouse genetics-answering fundamental questions about mammary gland biology. Trends Endocrinol. Metab. 2001, 12:402-408.
47. Sultan A.S., Brim H., Sherif Z.A. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition. Cancer Sci. 2008, 99:272-279.
48. Tiran Z., Elson A. Whole mount analysis of mammary gland structure in PTP epsilon transgenic mice. Methods Enzymol. 2003, 366:124-132.
49. Tomar A., Lim S.T., Lim Y., Schlaepfer D.D. A FAK-p120RasGAP-p190RhoGAP complex regulates polarity in migrating cells. J. Cell Sci. 2009, 122:1852-1862.
50. Wagner K.U., Wall R.J., St-Onge L., Gruss P., Wynshaw-Boris A., Garrett L., Li M., Furth P.A., Hennighausen L. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 1997, 25:4323-4330.
51. Wagner K.U., McAllister K., Ward T., Davis B., Wiseman R., Hennighausen L. Spatial and temporal expression of the Cre gene under control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res. 2001, 10:545-553.
52. Wang Y., Selden A.C., Morgan N., Stamp G.W., Hodgson H.J. Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am. J. Pathol. 1994, 144:675-682.
53. Watt F.M., Hodivala K.J. Cell adhesion: fibronectin and integrin knockouts come unstuck. Curr. Biol. 1994, 4:270-272.
54. Weibel E.R., Bolender R.P. Stereological Techniques for electron microscopic morphometry. Principles and Techniques of Electron Microscopy 1973, Vol. 3:237-296. M.A. Hayat (Ed.).
55. White D.E., Kurpios N.A., Zuo D., Hassell J.A., Blaess S., Mueller U., Mueller W.J. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 2004, 6:159-170.
56. Wierzbicka-Patynowski I., Schwarzbauer J.E. The ins and outs of fibronectin assembly. J. Cell Sci. 2003, 116:3269-3276.
57. Williams C.M., Engler A.J., Slone R.D., Galante L.L., Schwarzbauer J.E. Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation. Cancer Res. 2008, 68:3185-3192.
58. Woodward T.L., Xie J.W., Haslam S.Z. The role of mammary stroma in modulating the proliferative response to ovarian hormones in the normal mammary gland. J. Mammary Gland Biol. Neoplasia 1998, 3:117-131.
59. Woodward T.L., Mienaltowski A.S., Modi R.R., Bennett J.M., Haslam S.Z. Fibronectin and the alpha5beta1 integrin are under developmental and ovarian steroid regulation in the normal mouse mammary gland. Endocrinology 2001, 142:3214-3222.
60. Yang Y., Spitzer E., Meyer D., Sachs M., Niemann C., Hartmann G., Weidner K.M., Birchmeier C., Birchmeier W. Sequential requirement of HGF and neuregulin in morphogenesis and differentiation of the mammary gland. J. Cell Biol. 1995, 131:215-226.
61. Zhou X., Rowe R.G., Hiraoka N., George J.P., Wirtz D., Mosher D.F., Virtanen I., Chernousov M.A., Weiss S.J. Fibronectin fibrillogenesis regulates three-dimensional neovessel formation. Genes Dev. 2008, 22:1231-1243.